DSW Capital plc (AIM:DSW)

Market Cap	14.58M
Revenue (ttm)	4.86M
Net Income (ttm)	984.00K
Shares Out	25.13M
EPS (ttm)	0.04
PE Ratio	14.50
Forward PE	7.95
Dividend	0.03 (5.17%)
Ex-Dividend Date	Sep 11, 2025

Volume	9,977
Average Volume	15,814
Open	56.50
Previous Close	58.00
Day's Range	56.50 - 62.00
52-Week Range	40.60 - 77.00
Beta	0.28
RSI	49.11
Earnings Date	Jul 8, 2025

About Revance Therapeutics

DSW Capital plc provides professional services in the United Kingdom. It offers asset based lending risk management, business planning and recovery, corporate finance advice, debt and tax advisory, DSW venture, financial due diligence, equity finance, and R and D tax services. It also provides legal services to professionals. The company was founded in 2002 and is headquartered in Warrington, the United Kingdom.

• Industry: Specialty Business Services
• Sector: Industrials
• Founded: 2002
• Employees: 19
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DSW

Financial Performance

In 2024, DSW Capital's revenue was 4.86 million, an increase of 110.08% compared to the previous year's 2.31 million. Earnings were 984,000, an increase of 1071.43%.